Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic stability during carotid endarterectomy in elderly patients: LENOXe (xenon) versus sevoflurane
2009-012810-29Phase 4Active
- Sponsor
- Air Liquide
- Start
- May 2009
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of xenon and sevoflurane in carotid atheroma (CAS) (2 arms), sponsored by Air Liquide. Primary endpoint: Intraoperative hemodynamic stability. Started May 2009; status: active.
02
Drugs
xenonsevoflurane
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on 2009-012810-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012810-29.